News & Perspective

Aug 14, 2019

Aug 14, 2019
Peru TB detection

FDA approves new drug for highly resistant tuberculosis

The shorter, simpler regimen with the new drug is poised to improve treatment against a difficult disease and to lower costs.

Mar 21, 2019

Mar 21, 2019
Lung x-ray on tablet

TB in US at all-time low, but global decline small

As has been the case, California, Florida, New York, and Texas reported half of all TB cases.

Mar 19, 2019

Mar 19, 2019
Using stethoscope to assess lungs

Report highlights success, challenges in fight to end TB

Though incidence is down, treatment success for resistant strains is low.

Mar 14, 2019

Mar 14, 2019
Mycobacterium tuberculosis bacteria

Trial data support shorter drug-resistant TB regimen

Short-course therapy led to a favorable outcome in 79% of patients, compared with 80% in long-course patients.

Jan 09, 2019

Jan 09, 2019
Doctor prescribing using electronic tablet

Study sheds more light on delamanid role in treating MDR-TB

Safety profile was good, and sensitivity analysis favored delamanid as part of MDR-TB treatment.

Sep 27, 2018

Sep 27, 2018
DNA test genetic sequencing

Study heralds genetic era of TB drug susceptibility testing

Whole-genome sequencing could lead to faster, more accurate resistance testing.

Sep 18, 2018

Sep 18, 2018
Mycobacterium tuberculosis bacteria

WHO report warns efforts to end TB are falling short

TB remains high in many low- and middle-income nations, and about 558,000 people in 2017 developed rifampicin-resistant TB.

Sep 07, 2018

Sep 07, 2018
Capsules and syringe

Study provides data behind new MDR-TB guidance

Newer and repurposed drugs produced better results and fewer deaths than older treatments did.

Aug 20, 2018

Aug 20, 2018
MDR-TB detection

WHO revises MDR-TB treatment with focus on oral drugs

The changes prioritize newer medications and oral regimens over injectable drugs.

Jul 11, 2018

Jul 11, 2018
Tuberculosis in lungs

South African TB study finds lower death rate with bedaquiline

"Our results justify consideration for revised recommendations from WHO and wider use of bedaquiline," the authors write.

Pages

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»